Empagliflozin-Ameliorates-Obesity-Related-Cardiac-Dysfunction-by-Regulating-Sestrin2-Mediated-AMPK-mTOR-Signaling.jpg

Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice